Stallion India Fluorochemicals Limited reported a net profit of ₹1,856.58 lakh for the quarter ended June 30, 2026, up 79% from ₹1,036.32 lakh in Q1FY25. The surge was driven by a 10% year-on-year rise in revenue from operations to ₹12,144.60 lakh, alongside significant reductions in cost of materials consumed and finance costs. Profit before tax climbed to ₹2,478.88 lakh from ₹1,386.14 lakh in the prior year period, reflecting improved operational efficiency.

The Board of Directors approved the unaudited financial results on August 12, 2026, along with the Limited Review Report issued by Statutory Auditors Mittal & Associates. The company’s business operates within a single segment: the manufacture of industrial gases. Consequently, disclosures under Ind AS 108 for operating segments were not reported separately. The results were prepared in accordance with Ind AS 34 and Section 133 of the Companies Act, 2013.

Financial Performance

Revenue from operations increased to ₹12,144.60 lakh in Q1FY26, compared to ₹11,047.19 lakh in Q1FY25. Other income saw a substantial jump to ₹322.97 lakh from ₹7.37 lakh in the corresponding previous period. Total income stood at ₹12,467.57 lakh.

Expenses management contributed to the bottom-line growth. Cost of materials consumed decreased to ₹7,585.32 lakh from ₹9,526.02 lakh in Q1FY25. Finance costs dropped significantly to ₹9.18 lakh from ₹21.74 lakh. Employee benefits expense remained stable at ₹238.71 lakh. Total expenses for the quarter were ₹9,988.70 lakh.

Earnings per share (basic and diluted) rose to ₹1.60 from ₹1.15 in the previous year. The net worth of the company increased to ₹69,918.33 lakh as of June 30, 2026, from ₹31,027.02 lakh a year ago, reflecting capital raised through its Initial Public Offer (IPO).

IPO Proceeds Utilization

The Company received net proceeds of ₹14,474.87 lakh from its fresh issue of equity shares, after deducting IPO expenses of ₹1,598.00 lakh. As of June 30, 2026, the utilization of these proceeds included:

• Working Capital: ₹10,270.53 lakh utilized against an allocation of ₹9,441.80 lakh, resulting in an over-utilization of ₹828.73 lakh.
• Capital Expenditure (Khalapur): ₹2,661.77 lakh utilized for the Semi-conductor & Specialty Gas facility and land acquisition, exceeding the allocated ₹2,574.66 lakh by ₹87.11 lakh.
• Capital Expenditure (Mambattu): ₹1,100.75 lakh utilized for the Refrigerant debulking & blending facility, with ₹1,016.78 lakh remaining unutilized from the ₹2,117.53 lakh allocation.
• General Corporate Purposes: Fully utilized at ₹340.88 lakh.
• Issue Related Expenses: ₹1,198.92 lakh utilized, with ₹399.08 lakh remaining.

Unutilized proceeds were temporarily invested in fixed deposits and held in monitoring agency accounts. A special resolution passed on May 30, 2026, revised the allocation to include land acquisition in Khalapur, Maharashtra, resulting in a differential cost of ₹0.13 crore.

What the Numbers Show

The sharp 79% increase in net profit is primarily driven by operational leverage rather than just top-line growth. While revenue grew by 10%, total expenses grew by only 3%. This divergence was largely due to a 20% reduction in cost of materials consumed and a 58% drop in finance costs. Additionally, other income surged to ₹322.97 lakh from a negligible ₹7.37 lakh in Q1FY25, contributing significantly to the total income growth. This indicates a period of strong margin expansion and effective cost control following the company's public listing.

Corporate Governance and AGM

The Board approved the Directors' Report, Management Discussion and Analysis Report, and Corporate Governance Report for FY26. The Annual General Meeting (AGM) is scheduled for September 21, 2026, at 4:00 PM. The book closure period will be from September 15, 2026, to September 21, 2026 (both days inclusive). Shareholders will vote on the regularization of Ms. Swati Ghosh (DIN: 08789050) from Additional Independent Director to Woman Independent Director.

Stallion India Fluorochemicals Limited will engage with analysts and investors on July 21, 2026, to discuss its business performance and outlook. The management has scheduled a virtual meeting at the registered office of the company to interact with various financial institutions. The company confirmed that no unpublished price sensitive information (UPSI) will be shared during these interactions.

The meeting is being held pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was submitted to the National Stock Exchange of India Limited (NSE) and BSE Limited on July 16, 2026, by Govind Rao, the Company Secretary & Compliance Officer.

The schedule includes participation from ten entities, ranging from wealth management firms to portfolio management services. Barclays Wealth is listed for a group meet, while other participants include Ambit Portfolio Management Services (PMS), ICICI Securities Limited, and Nuvama Wealth Management.

The company noted that the schedule is subject to change due to exigencies on the part of the company or the concerned analysts and investors. Any modifications to the schedule will be communicated to the stock exchanges as required.